Hugo Martin, INSERM – Paris Sud
vendredi 8 avril 2022 @ 11h00 – 12h00 –
Glioblastoma cell variability and circadian rhythms control temozolomide efficacy: from cellular pharmacokinetics-pharmacodynamics to heterogeneous cancer cell population models